BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

256 related articles for article (PubMed ID: 17063150)

  • 61. Norepinephrine transporter gene (SLC6A2) is involved with methylphenidate response in Korean children with attention deficit hyperactivity disorder.
    Song J; Song DH; Jhung K; Cheon KA
    Int Clin Psychopharmacol; 2011 Mar; 26(2):107-13. PubMed ID: 21127421
    [TBL] [Abstract][Full Text] [Related]  

  • 62. The variable number of tandem repeats element in DAT1 regulates in vitro dopamine transporter density.
    VanNess SH; Owens MJ; Kilts CD
    BMC Genet; 2005 Nov; 6():55. PubMed ID: 16309561
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Regional brain perfusion before and after treatment with methylphenidate may be associated with the G1287A polymorphism of the norepinephrine transporter gene in children with attention-deficit/hyperactivity disorder.
    Park MH; Kim JW; Yang YH; Hong SB; Park S; Kang H; Kim BN; Shin MS; Yoo HJ; Cho SC
    Neurosci Lett; 2012 Apr; 514(2):159-63. PubMed ID: 22405810
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Absence of association with DAT1 polymorphism and response to methylphenidate in a sample of adults with ADHD.
    Mick E; Biederman J; Spencer T; Faraone SV; Sklar P
    Am J Med Genet B Neuropsychiatr Genet; 2006 Dec; 141B(8):890-4. PubMed ID: 16917950
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Pharmacogenetics of response to methylphenidate in adult patients with Attention-Deficit/Hyperactivity Disorder (ADHD): a systematic review.
    Contini V; Rovaris DL; Victor MM; Grevet EH; Rohde LA; Bau CH
    Eur Neuropsychopharmacol; 2013 Jun; 23(6):555-60. PubMed ID: 22709890
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Polymorphisms TaqI A of the DRD2, BalI of the DRD3, exon III repeat of the DRD4, and 3' UTR VNTR of the DAT: association with childhood ADHD in male African-Caribbean cocaine dependents?
    Ballon N; Leroy S; Roy C; Bourdel MC; Olie JP; Charles-Nicolas A; Krebs MO; Poirier MF
    Am J Med Genet B Neuropsychiatr Genet; 2007 Dec; 144B(8):1034-41. PubMed ID: 17671965
    [TBL] [Abstract][Full Text] [Related]  

  • 67. [Response With Methylphenidate to ADHD-Like Symptoms in Pervasive Developmental Disorder: Does CES-1 Enzyme Gene Polymorphism Have a Role?].
    Akyol Ardıç Ü; Ercan ES; Aygüneş D; Yüce D; Durak S; Kosova B
    Turk Psikiyatri Derg; 2017; 28(2):89-94. PubMed ID: 29192941
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Association of dopamine, serotonin, and nicotinic gene polymorphisms with methylphenidate response in ADHD.
    Tharoor H; Lobos EA; Todd RD; Reiersen AM
    Am J Med Genet B Neuropsychiatr Genet; 2008 Jun; 147B(4):527-30. PubMed ID: 17948872
    [TBL] [Abstract][Full Text] [Related]  

  • 69. No association between VNTR polymorphisms of dopamine transporter gene and attention deficit hyperactivity disorder in Chinese children.
    Cheuk DK; Li SY; Wong V
    Am J Med Genet B Neuropsychiatr Genet; 2006 Mar; 141B(2):123-5. PubMed ID: 16402340
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Pharmacogenetics of methylphenidate in childhood attention-deficit/hyperactivity disorder: long-term effects.
    Gomez-Sanchez CI; Carballo JJ; Riveiro-Alvarez R; Soto-Insuga V; Rodrigo M; Mahillo-Fernandez I; Abad-Santos F; Dal-Ré R; Ayuso C
    Sci Rep; 2017 Sep; 7(1):10391. PubMed ID: 28871191
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Molecular imaging genetics of methylphenidate response in ADHD and substance use comorbidity.
    Szobot CM; Roman T; Hutz MH; Genro JP; Shih MC; Hoexter MQ; Júnior N; Pechansky F; Bressan RA; Rohde LA
    Synapse; 2011 Feb; 65(2):154-9. PubMed ID: 20593420
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Neurotrophin 3 genotype and emotional adverse effects of osmotic-release oral system methylphenidate (OROS-MPH) in children with attention-deficit/hyperactivity disorder.
    Park S; Kim BN; Kim JW; Shin MS; Cho SC; Kim JH; Son JW; Shin YM; Chung US; Han DH
    J Psychopharmacol; 2014 Mar; 28(3):220-6. PubMed ID: 23471121
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Meta-Analysis Reveals Significant Association of the 3'-UTR VNTR in SLC6A3 with Alcohol Dependence.
    Ma Y; Fan R; Li MD
    Alcohol Clin Exp Res; 2016 Jul; 40(7):1443-53. PubMed ID: 27219321
    [TBL] [Abstract][Full Text] [Related]  

  • 74. The SLC6A3 gene polymorphism is related to the development of attentional functions but not to ADHD.
    Kuc K; Bielecki M; Racicka-Pawlukiewicz E; Czerwinski MB; Cybulska-Klosowicz A
    Sci Rep; 2020 Apr; 10(1):6176. PubMed ID: 32277231
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Dopamine transporter genotype influences the attention deficit in Korean boys with ADHD.
    Oh KS; Shin DW; Oh GT; Noh KS
    Yonsei Med J; 2003 Oct; 44(5):787-92. PubMed ID: 14584093
    [TBL] [Abstract][Full Text] [Related]  

  • 76. SLC6A3 polymorphism and response to methylphenidate in children with ADHD: A systematic review and meta-analysis.
    Soleimani R; Salehi Z; Soltanipour S; Hasandokht T; Jalali MM
    Am J Med Genet B Neuropsychiatr Genet; 2018 Apr; 177(3):287-300. PubMed ID: 29171685
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Relation between therapeutic response and side effects induced by methylphenidate as observed by parents and teachers of children with ADHD.
    Lee J; Grizenko N; Bhat V; Sengupta S; Polotskaia A; Joober R
    BMC Psychiatry; 2011 Apr; 11():70. PubMed ID: 21510895
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Influence of striatal dopamine transporter availability on the response to methylphenidate in adult patients with ADHD.
    Krause J; la Fougere C; Krause KH; Ackenheil M; Dresel SH
    Eur Arch Psychiatry Clin Neurosci; 2005 Dec; 255(6):428-31. PubMed ID: 16091862
    [TBL] [Abstract][Full Text] [Related]  

  • 79. No significant association between response to methylphenidate and genes of the dopaminergic and serotonergic systems in a sample of Brazilian children with attention-deficit/hyperactivity disorder.
    Zeni CP; Guimarães AP; Polanczyk GV; Genro JP; Roman T; Hutz MH; Rohde LA
    Am J Med Genet B Neuropsychiatr Genet; 2007 Apr; 144B(3):391-4. PubMed ID: 17171656
    [TBL] [Abstract][Full Text] [Related]  

  • 80. A promoter polymorphism (-839 C > T) at the dopamine transporter gene is associated with attention deficit/hyperactivity disorder in Brazilian children.
    Genro JP; Zeni C; Polanczyk GV; Roman T; Rohde LA; Hutz MH
    Am J Med Genet B Neuropsychiatr Genet; 2007 Mar; 144B(2):215-9. PubMed ID: 17044101
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.